Functional Improvement and UTC of the Achilles Tendon After Sodium Hyaluronate Injection for Plantaris Syndrome
NCT ID: NCT03077009
Last Updated: 2017-03-10
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Clinical Phase
PHASE4
Total Enrollment
33 participants
Study Classification
INTERVENTIONAL
Study Start Date
2017-03-20
Study Completion Date
2020-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a study to assess the benefit of sodium hyaluronate (Ostenil) injection for plantaris friction syndrome (PFS) associated with midportion Achilles tendinopathy. Functional outcome scores will be recorded prior to treatment and at regular intervals up to 2 years. Changes in tendon structure will be assessed using ultrasonographic tissue characterisation (UTC). UTC will be performed prior to treatment and also at regular intervals up to 6 months following injection.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hyaluronan in the Treatment of Painful Achilles Tendinopathy.
NCT01954108
Tendinopathy
COMPLETED
NA
Platelet Rich Plasma in Plantar Fasciitis
NCT05339542
Plantar Fascitis
COMPLETED
NA
Achilles Pain Block
NCT03316378
Achilles Tendon Pain
COMPLETED
PHASE2/PHASE3
"NSAIDs in Acute Achilles Tendinopathy: Effect on Pain Control, Leg Stiffness and Functional Recovery in Athletes"
NCT00792376
Achilles Tendinopathy
COMPLETED
PHASE4
One Cause of Heel Pain is Plantar Fasciopathy (PF). In Most Cases, a Heel Spur is Frequently Present Alongside PF. We Aim to Evaluate the Efficacy of Corticosteroid Injection and Radiofrequency Ablation, Along With Tissue Elasticity Assessed by Ultrasound, in Patients With Chronic Pain (≥6 Months).
NCT07120204
Plantar Fasciopathy
Chronic Pain
Corticosteroid Injection
+2 more
NOT_YET_RECRUITING
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Introduction Midportion Achilles tendinopathy is a common source of disability, with typical features including pain, swelling and dysfunction \[Roche\]. The causes are multifactorial \[Roche\]. First line treatment is typically non operative and includes an eccentric loading program \[Alfredson-1998\], high volume injection \[Chan\], platelet rich plasma \[de Vos JAMA 2010\], sclerosing agent injections \[Alfredson-2005\] , shock wave therapy \[Lynen\]\[Saxena\] and for resistant cases, surgery \[Alfredson-2011\].
Plantaris friction syndrome (PFS) One possible cause of midportion Achilles tendinopathy is plantaris friction syndrome (PFS). In this subset of patients, the pain is located to the postero-medial aspect of the Achilles tendon. The plantaris tendon is a small vestigial tendon originating from the lateral femoral condyle, crossing obliquely to the medial side of the Achilles tendon and inserting into the medial side of the calcaneum. The anatomy at the insertion is highly variable. Over 80% of plantaris tendons insert separately to the Achilles tendon \[Daseler\]. Biomechanical evidence suggests that the plantaris tendon is stiffer and stronger than the Achilles tendon \[Lintz\]. Under load therefore, differential movement between the tendons may occur. Subsequently the plantaris tendon can become tendinopathic and thickened. Adhesions may develop between it and the adjacent Achilles tendon \[Bedi\], initiating medial midportion Achilles tendinopathy. Sensitization of the nerve endings in the fat layer between the Achilles and plantaris has also been demonstrated. The optimal treatment of PFS is currently unclear. Treatments include physiotherapy, injection and surgical excision \[Bedi\]\[Pearce\]\[Weinberg\]\[Calder-2014\]\[Alfredson-2011\].
Sodium Hyaluronate One potential treatment is injection with sodium hyaluronate which is a viscosupplement solution. It has primarily been used for joint lubrication in arthropathy, but can also be used for tendinopathy \[Lynen\]. Ostenil Tendon is a sodium hyaluronate solution that potentially acts in several ways to reduce pain. One mode is to act as a lubricant between tendons or between the tendon and its sheath \[Akasaka 2005\]\[Akasaka 2006\]\[Nishida\]\[Kumar\]\[St Onge\]. It may also promote tendon healing \[Chen\]\[Yagishta\]. According to unpublished work, Ostenil Tendon significantly reduced pain at 6 weeks for peroneal and also midportion Achilles tendinopathy \[Company literature\]. It may also act as a medium to allow free passage of nutrients to the tendon \[Hagberg\]. Sodium hyaluronate injection placed in the interval between the plantaris tendon and Achilles tendon could potentially reduce friction and subsequently pain. Although the effect of sodium hyaluronate injections have been reported in the hip and knee, no previous studies have reported its efficacy for PFS. The primary aim of the current study is to assess the impact of sodium hyaluronate injections in patients with PFS.
Ultrasound tissue characterization Methods of assessing the Achilles tendon for tendinopathy continue to be debated. Common methods include ultrasound and magnetic resonance imaging \[Khan\]\[Astrom\]. A novel assessment tool is ultrasound tissue characterization (UTC) which uses ultrasound to quantify tendon structure \[van Schie\]\[Docking-2015\]\[Docking-2016\]\[Rosengarten\]\[Bedi\].
Structural integrity of the tendon matrix is categorized in four echo types (1-green, 2-blue, 3-red, 4-black). Echo types 1 and 2 reflect aligned fibrillar structure, whereas types 3 and 4 indicate disorganised tissue \[Bedi\]. The entire length of the tendon can be analyzed with a minimum detectable difference in structure to be 1% \[Docking-2015\]. Bedi et al showed significant improvement in UTC following excision of plantaris for midportion Achilles tendinopathy \[Bedi\]. However this study was limited because UTC images were not performed at a uniform time pre- and post- surgery \[Bedi\]. Masci et al found improvement in UTC echo-structure at 6 month follow-up post plantaris excision combined with improvement in VISA-A scores \[Masci\]. It is debated as to whether fibrillar integrity and matrix organisation correlate with symptoms. For example, a study in elite Australian football players showed that UTC changed following pre-season training, but all players remained asymptomatic at the start and end of the study \[Rosengarten\]. Ultrasound studies have also questioned the relationship of tendon structure in tendinopathy and patient function \[Khan\]\[McAuliffe\]. In a study of gymnasts, clinical assessment has only moderate correlation with ultrasound and MR appearances \[Emerson\].
Given the novelty of UTC for the Achilles tendon, the secondary aim of this study is to assess whether UTC changes following treatment for PFS and to correlate any changes with functional outcome scores.
Aims summary
1. To determine changes in Achilles tendon matrix structure using UTC before and after treatment (6 month follow up)
2. To assess medium term (2 years) effectiveness of a sodium hyaluronate injection in the space between the plantaris and Achilles tendons for midportion Achilles tendinopathy which is associated with PFS.
3. To correlate UTC changes with functional scores
Hypothesis The alternate hypotheses are that sodium hyaluronate injection improves both 1) function and 2) structure of the Achilles tendon for PFS.
Outcome measures
* Ultrasonographic tissue characterisation (UTC)
* Functional scores - Victorian Institute of Sports Assessment-Achilles (VISA-A) \[Robinson\] and Foot and Ankle Outcome scores (FAOS)
Methods This will be a single centre prospective case series of patients in whom PFS has been diagnosed based upon clinical examination by a Consultant foot \& ankle surgeon, physiotherapist and imaging. Patients will be prospectively followed up with pre and post intervention patient reported outcome scores.
Sample Population 33 patients diagnosed with PFS will be identified and invited to participate in the study once the decision has been made to treat with sodium hyaluronate.
Inclusion Criteria Patients aged 18-75 years Able to provide informed consent Diagnosis of PFS requiring sodium hyaluronate injection Able to follow physiotherapy instructions Exclusion Criteria Previous Achilles tendon surgery Previous injection therapy for Achilles midportion tendinopathy Age \< 18 \>75 years Active local infection Active bleeding disorder or anticoagulant therapy Allergies to lignocaine or sodium hyaluronate Active deep vein thrombosis
Patient Recruitment and Consent All patients will be given the information sheet regarding the study and will be consented by the CI or the Fortius foot and ankle fellow. All be patients will be recruited and treated at the Fortius Clinic.
Proposed treatment will include one or two sodium hyaluronate (Ostenil Tendon) injections. Physiotherapy is a routine part of current treatment, usually provided off site.
Injection protocol All injections will be carried out by a Consultant Radiologist at the Fortius Clinic. Approximately 3-5mm of 1% lignocaine will be injected to create a plane between Plantaris and the medial Achilles tendon. Subsequently, 2-3ml of Ostenil Tendon (sodium hyaluronate) will be injected into the space between the Achilles and plantaris tendons.
UTC assessment UTC assessment at 6 and 12 weeks is a routine part of our current treatment protocol for PFS and allows guidance of treatment. Patients will have pre and post treatment UTC assessment of the Achilles tendon. For the purposes of the study, an extra UTC assessment will be performed at 6 months, during part of their routine clinical follow up appointment. This final UTC assessment will be provided free to the patients. All UTC assessments will be conducted by the same experienced physiotherapist.
Follow up Patient reported outcome scores will be completed prior to treatment and at 6 weeks, 3 months,6 months, 1 and 2 years. Outcome scores at 1 and 2 years will be performed online via an automated email system.
UTC will be conducted at 6 weeks, 3 months and 6 months.
Ethical Issues:
Patients will be free to choose to participate or not in the study. If they choose not to participate it will not affect their treatment in any way.
No patient or volunteer will take part in the study without giving written informed consent and we will exclude those patients who are unable to give this consent.
Legal Issues:
There are no legal issues identified that will affect this study.
Management issues:
This study will take place at the Fortius Clinic, which is a private clinic. The patients included would be receiving one or two sodium hyaluronate injections, and two UTC assessments as part of the routine treatment of PFS. They will be charged for this as normal. There will be no additional charge for the final UTC assessment at 6 months.
Risks:
Patients agreeing to take part in the study will be receiving the routine treatment for PFS that they would be receiving even if the study was not taking place. There are therefore no additional risks to the patient.
Data collection All data collection will be done within the premises of the Fortius clinic by members of the clinical team, which includes a physiotherapist who works on site for the Tendon Performance Clinic. In addition to the outcome score and UTC data information regarding patient demographics, medical history and treatment will also be collected.
Data confidentiality Data will be stored in Fortius/Tendon Performance Clinic computers which are password protected and comply with information governance guidelines. No one outside the clinical team will have access to the data.
Any information that leaves the clinic will have patient identifiable information removed. All of the results will be analysed and published using anonymous data only. Details about patient's involvement in the study will also be recorded in patients' medical records held by the Fortius Clinic/Tendon Performance Clinic.
Power analysis In 18 asymptomatic elite Australian football players, UTC demonstrated improvement in Achilles tendon structure over a 5 month period following pre-season training \[Docking-2016\]. Bedi et al reported UTC changes following Plantaris excision and ventral paratendinous Achilles tendon scraping in athletes. In 11 patients, the fibrillar structure of the Achilles tendon improved from 90 to 96%, SD 8% p=.04. Mean VISA-A scores improved from 51 to 95, SD 12, p=.0001. Regarding sodium hyaluronate injection, only one study was found assessing its use for midportion Achilles tendinopathy \[Lynen\]. Lynen et al compared two paratendinous injections with three ESWT treatments given at weekly intervals in 62 patients. No previous studies have assessed its use for PFS.
Considering the limited evidence available, we estimate the sample size required to demonstrate improvements in UTC (assuming change in type 1 and 2 echo types from 90% to 96%, SD 8%) to be at least 28 patients. With an expected drop out rate of 15%, we plan to recruit 33 patients to the study.
Statistical analysis Analyses will be conducted using a statistical package. A paired t test will be used to compare pre and post treatment VISA-A scores. UTC results will be compared using Wilcoxon signed rank test (non parametric data). A p value of 0.05 will be defined as statistically significant.
Plantaris friction syndrome (PFS) One possible cause of midportion Achilles tendinopathy is plantaris friction syndrome (PFS). In this subset of patients, the pain is located to the postero-medial aspect of the Achilles tendon. The plantaris tendon is a small vestigial tendon originating from the lateral femoral condyle, crossing obliquely to the medial side of the Achilles tendon and inserting into the medial side of the calcaneum. The anatomy at the insertion is highly variable. Over 80% of plantaris tendons insert separately to the Achilles tendon \[Daseler\]. Biomechanical evidence suggests that the plantaris tendon is stiffer and stronger than the Achilles tendon \[Lintz\]. Under load therefore, differential movement between the tendons may occur. Subsequently the plantaris tendon can become tendinopathic and thickened. Adhesions may develop between it and the adjacent Achilles tendon \[Bedi\], initiating medial midportion Achilles tendinopathy. Sensitization of the nerve endings in the fat layer between the Achilles and plantaris has also been demonstrated. The optimal treatment of PFS is currently unclear. Treatments include physiotherapy, injection and surgical excision \[Bedi\]\[Pearce\]\[Weinberg\]\[Calder-2014\]\[Alfredson-2011\].
Sodium Hyaluronate One potential treatment is injection with sodium hyaluronate which is a viscosupplement solution. It has primarily been used for joint lubrication in arthropathy, but can also be used for tendinopathy \[Lynen\]. Ostenil Tendon is a sodium hyaluronate solution that potentially acts in several ways to reduce pain. One mode is to act as a lubricant between tendons or between the tendon and its sheath \[Akasaka 2005\]\[Akasaka 2006\]\[Nishida\]\[Kumar\]\[St Onge\]. It may also promote tendon healing \[Chen\]\[Yagishta\]. According to unpublished work, Ostenil Tendon significantly reduced pain at 6 weeks for peroneal and also midportion Achilles tendinopathy \[Company literature\]. It may also act as a medium to allow free passage of nutrients to the tendon \[Hagberg\]. Sodium hyaluronate injection placed in the interval between the plantaris tendon and Achilles tendon could potentially reduce friction and subsequently pain. Although the effect of sodium hyaluronate injections have been reported in the hip and knee, no previous studies have reported its efficacy for PFS. The primary aim of the current study is to assess the impact of sodium hyaluronate injections in patients with PFS.
Ultrasound tissue characterization Methods of assessing the Achilles tendon for tendinopathy continue to be debated. Common methods include ultrasound and magnetic resonance imaging \[Khan\]\[Astrom\]. A novel assessment tool is ultrasound tissue characterization (UTC) which uses ultrasound to quantify tendon structure \[van Schie\]\[Docking-2015\]\[Docking-2016\]\[Rosengarten\]\[Bedi\].
Structural integrity of the tendon matrix is categorized in four echo types (1-green, 2-blue, 3-red, 4-black). Echo types 1 and 2 reflect aligned fibrillar structure, whereas types 3 and 4 indicate disorganised tissue \[Bedi\]. The entire length of the tendon can be analyzed with a minimum detectable difference in structure to be 1% \[Docking-2015\]. Bedi et al showed significant improvement in UTC following excision of plantaris for midportion Achilles tendinopathy \[Bedi\]. However this study was limited because UTC images were not performed at a uniform time pre- and post- surgery \[Bedi\]. Masci et al found improvement in UTC echo-structure at 6 month follow-up post plantaris excision combined with improvement in VISA-A scores \[Masci\]. It is debated as to whether fibrillar integrity and matrix organisation correlate with symptoms. For example, a study in elite Australian football players showed that UTC changed following pre-season training, but all players remained asymptomatic at the start and end of the study \[Rosengarten\]. Ultrasound studies have also questioned the relationship of tendon structure in tendinopathy and patient function \[Khan\]\[McAuliffe\]. In a study of gymnasts, clinical assessment has only moderate correlation with ultrasound and MR appearances \[Emerson\].
Given the novelty of UTC for the Achilles tendon, the secondary aim of this study is to assess whether UTC changes following treatment for PFS and to correlate any changes with functional outcome scores.
Aims summary
1. To determine changes in Achilles tendon matrix structure using UTC before and after treatment (6 month follow up)
2. To assess medium term (2 years) effectiveness of a sodium hyaluronate injection in the space between the plantaris and Achilles tendons for midportion Achilles tendinopathy which is associated with PFS.
3. To correlate UTC changes with functional scores
Hypothesis The alternate hypotheses are that sodium hyaluronate injection improves both 1) function and 2) structure of the Achilles tendon for PFS.
Outcome measures
* Ultrasonographic tissue characterisation (UTC)
* Functional scores - Victorian Institute of Sports Assessment-Achilles (VISA-A) \[Robinson\] and Foot and Ankle Outcome scores (FAOS)
Methods This will be a single centre prospective case series of patients in whom PFS has been diagnosed based upon clinical examination by a Consultant foot \& ankle surgeon, physiotherapist and imaging. Patients will be prospectively followed up with pre and post intervention patient reported outcome scores.
Sample Population 33 patients diagnosed with PFS will be identified and invited to participate in the study once the decision has been made to treat with sodium hyaluronate.
Inclusion Criteria Patients aged 18-75 years Able to provide informed consent Diagnosis of PFS requiring sodium hyaluronate injection Able to follow physiotherapy instructions Exclusion Criteria Previous Achilles tendon surgery Previous injection therapy for Achilles midportion tendinopathy Age \< 18 \>75 years Active local infection Active bleeding disorder or anticoagulant therapy Allergies to lignocaine or sodium hyaluronate Active deep vein thrombosis
Patient Recruitment and Consent All patients will be given the information sheet regarding the study and will be consented by the CI or the Fortius foot and ankle fellow. All be patients will be recruited and treated at the Fortius Clinic.
Proposed treatment will include one or two sodium hyaluronate (Ostenil Tendon) injections. Physiotherapy is a routine part of current treatment, usually provided off site.
Injection protocol All injections will be carried out by a Consultant Radiologist at the Fortius Clinic. Approximately 3-5mm of 1% lignocaine will be injected to create a plane between Plantaris and the medial Achilles tendon. Subsequently, 2-3ml of Ostenil Tendon (sodium hyaluronate) will be injected into the space between the Achilles and plantaris tendons.
UTC assessment UTC assessment at 6 and 12 weeks is a routine part of our current treatment protocol for PFS and allows guidance of treatment. Patients will have pre and post treatment UTC assessment of the Achilles tendon. For the purposes of the study, an extra UTC assessment will be performed at 6 months, during part of their routine clinical follow up appointment. This final UTC assessment will be provided free to the patients. All UTC assessments will be conducted by the same experienced physiotherapist.
Follow up Patient reported outcome scores will be completed prior to treatment and at 6 weeks, 3 months,6 months, 1 and 2 years. Outcome scores at 1 and 2 years will be performed online via an automated email system.
UTC will be conducted at 6 weeks, 3 months and 6 months.
Ethical Issues:
Patients will be free to choose to participate or not in the study. If they choose not to participate it will not affect their treatment in any way.
No patient or volunteer will take part in the study without giving written informed consent and we will exclude those patients who are unable to give this consent.
Legal Issues:
There are no legal issues identified that will affect this study.
Management issues:
This study will take place at the Fortius Clinic, which is a private clinic. The patients included would be receiving one or two sodium hyaluronate injections, and two UTC assessments as part of the routine treatment of PFS. They will be charged for this as normal. There will be no additional charge for the final UTC assessment at 6 months.
Risks:
Patients agreeing to take part in the study will be receiving the routine treatment for PFS that they would be receiving even if the study was not taking place. There are therefore no additional risks to the patient.
Data collection All data collection will be done within the premises of the Fortius clinic by members of the clinical team, which includes a physiotherapist who works on site for the Tendon Performance Clinic. In addition to the outcome score and UTC data information regarding patient demographics, medical history and treatment will also be collected.
Data confidentiality Data will be stored in Fortius/Tendon Performance Clinic computers which are password protected and comply with information governance guidelines. No one outside the clinical team will have access to the data.
Any information that leaves the clinic will have patient identifiable information removed. All of the results will be analysed and published using anonymous data only. Details about patient's involvement in the study will also be recorded in patients' medical records held by the Fortius Clinic/Tendon Performance Clinic.
Power analysis In 18 asymptomatic elite Australian football players, UTC demonstrated improvement in Achilles tendon structure over a 5 month period following pre-season training \[Docking-2016\]. Bedi et al reported UTC changes following Plantaris excision and ventral paratendinous Achilles tendon scraping in athletes. In 11 patients, the fibrillar structure of the Achilles tendon improved from 90 to 96%, SD 8% p=.04. Mean VISA-A scores improved from 51 to 95, SD 12, p=.0001. Regarding sodium hyaluronate injection, only one study was found assessing its use for midportion Achilles tendinopathy \[Lynen\]. Lynen et al compared two paratendinous injections with three ESWT treatments given at weekly intervals in 62 patients. No previous studies have assessed its use for PFS.
Considering the limited evidence available, we estimate the sample size required to demonstrate improvements in UTC (assuming change in type 1 and 2 echo types from 90% to 96%, SD 8%) to be at least 28 patients. With an expected drop out rate of 15%, we plan to recruit 33 patients to the study.
Statistical analysis Analyses will be conducted using a statistical package. A paired t test will be used to compare pre and post treatment VISA-A scores. UTC results will be compared using Wilcoxon signed rank test (non parametric data). A p value of 0.05 will be defined as statistically significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Plantaris Friction Syndrome
Non-Insertional Achilles Tendinopathy
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
NA
Intervention Model
SINGLE_GROUP
Primary Study Purpose
TREATMENT
Blinding Strategy
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment arm
Patients with confirmed plantaris friction syndrome will be offered hyaluronic acid injection into the space between the Plantaris and Achilles tendons
Group Type
EXPERIMENTAL
Hyaluronic Acid
Intervention Type
DRUG
Ultrasound guided injection for plantaris friction syndrome
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyaluronic Acid
Ultrasound guided injection for plantaris friction syndrome
Intervention Type
DRUG
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Ostenil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged 18-75 years
* Able to provide informed consent
* Diagnosis of PFS requiring sodium hyaluronate injection
* Able to follow physiotherapy instructions
* Able to provide informed consent
* Diagnosis of PFS requiring sodium hyaluronate injection
* Able to follow physiotherapy instructions
Exclusion Criteria
* Previous Achilles tendon surgery
* Previous injection therapy for Achilles midportion tendinopathy
* Age \< 18 \>75 years
* Active local infection
* Active bleeding disorder or anticoagulant therapy
* Allergies to lignocaine or sodium hyaluronate
* Active deep vein thrombosis
* Previous injection therapy for Achilles midportion tendinopathy
* Age \< 18 \>75 years
* Active local infection
* Active bleeding disorder or anticoagulant therapy
* Allergies to lignocaine or sodium hyaluronate
* Active deep vein thrombosis
Minimum Eligible Age
18 Years
Maximum Eligible Age
75 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fortius Clinic
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Calder, MD FRCS
Role: PRINCIPAL_INVESTIGATOR
Fortius Clinic, London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fortius Clinic
London, , United Kingdom
Site Status
RECRUITING
Fortius Clinic
London, , United Kingdom
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
United Kingdom
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
St Onge R, Weiss C, Denlinger JL, Balazs EA. A preliminary assessment of Na-hyaluronate injection into "no man's land" for primary flexor tendon repair. Clin Orthop Relat Res. 1980 Jan-Feb;(146):269-75.
Reference Type
BACKGROUND
Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen. 1999 Mar-Apr;7(2):79-89. doi: 10.1046/j.1524-475x.1999.00079.x.
Reference Type
BACKGROUND
Yagishita K, Sekiya I, Sakaguchi Y, Shinomiya K, Muneta T. The effect of hyaluronan on tendon healing in rabbits. Arthroscopy. 2005 Nov;21(11):1330-6. doi: 10.1016/j.arthro.2005.08.020.
Reference Type
BACKGROUND
Akasaka T, Nishida J, Imaeda T, Shimamura T, Amadio PC, An KN. Effect of hyaluronic acid on the excursion resistance of tendon graft: a biomechanical in vitro study in a modified human model. Clin Biomech (Bristol). 2006 Oct;21(8):810-5. doi: 10.1016/j.clinbiomech.2006.04.007. Epub 2006 Jun 9.
Reference Type
BACKGROUND
Akasaka T, Nishida J, Araki S, Shimamura T, Amadio PC, An KN. Hyaluronic acid diminishes the resistance to excursion after flexor tendon repair: an in vitro biomechanical study. J Biomech. 2005 Mar;38(3):503-7. doi: 10.1016/j.jbiomech.2004.04.021.
Reference Type
BACKGROUND
Nishida J, Araki S, Akasaka T, Toba T, Shimamura T, Amadio PC, An KN. Effect of hyaluronic acid on the excursion resistance of tendon grafts. A biomechanical study in a canine model in vitro. J Bone Joint Surg Br. 2004 Aug;86(6):918-24. doi: 10.1302/0301-620x.86b6.14329.
Reference Type
BACKGROUND
Hagberg L, Gerdin B. Sodium hyaluronate as an adjunct in adhesion prevention after flexor tendon surgery in rabbits. J Hand Surg Am. 1992 Sep;17(5):935-41. doi: 10.1016/0363-5023(92)90474-4.
Reference Type
BACKGROUND
Bedi HS, Jowett C, Ristanis S, Docking S, Cook J. Plantaris Excision and Ventral Paratendinous Scraping for Achilles Tendinopathy in an Athletic Population. Foot Ankle Int. 2016 Apr;37(4):386-93. doi: 10.1177/1071100715619989. Epub 2015 Dec 4.
Reference Type
BACKGROUND
van Schie HT, de Vos RJ, de Jonge S, Bakker EM, Heijboer MP, Verhaar JA, Tol JL, Weinans H. Ultrasonographic tissue characterisation of human Achilles tendons: quantification of tendon structure through a novel non-invasive approach. Br J Sports Med. 2010 Dec;44(16):1153-9. doi: 10.1136/bjsm.2009.061010. Epub 2009 Aug 6.
Reference Type
BACKGROUND
Docking SI, Rosengarten SD, Cook J. Achilles tendon structure improves on UTC imaging over a 5-month pre-season in elite Australian football players. Scand J Med Sci Sports. 2016 May;26(5):557-63. doi: 10.1111/sms.12469. Epub 2015 May 5.
Reference Type
BACKGROUND
Docking SI, Rosengarten SD, Daffy J, Cook J. Structural integrity is decreased in both Achilles tendons in people with unilateral Achilles tendinopathy. J Sci Med Sport. 2015 Jul;18(4):383-7. doi: 10.1016/j.jsams.2014.06.004. Epub 2014 Jun 20.
Reference Type
BACKGROUND
Rosengarten SD, Cook JL, Bryant AL, Cordy JT, Daffy J, Docking SI. Australian football players' Achilles tendons respond to game loads within 2 days: an ultrasound tissue characterisation (UTC) study. Br J Sports Med. 2015 Feb;49(3):183-7. doi: 10.1136/bjsports-2013-092713. Epub 2014 Apr 15.
Reference Type
BACKGROUND
Pearce CJ, Carmichael J, Calder JD. Achilles tendinoscopy and plantaris tendon release and division in the treatment of non-insertional Achilles tendinopathy. Foot Ankle Surg. 2012 Jun;18(2):124-7. doi: 10.1016/j.fas.2011.04.008. Epub 2011 May 26.
Reference Type
BACKGROUND
Weinberg EP, Adams MJ, Hollenberg GM. Color Doppler sonography of patellar tendinosis. AJR Am J Roentgenol. 1998 Sep;171(3):743-4. doi: 10.2214/ajr.171.3.9725308. No abstract available.
Reference Type
BACKGROUND
Alfredson H. Midportion Achilles tendinosis and the plantaris tendon. Br J Sports Med. 2011 Oct;45(13):1023-5. doi: 10.1136/bjsports-2011-090217. Epub 2011 May 31.
Reference Type
BACKGROUND
Calder JD, Freeman R, Pollock N. Plantaris excision in the treatment of non-insertional Achilles tendinopathy in elite athletes. Br J Sports Med. 2015 Dec;49(23):1532-4. doi: 10.1136/bjsports-2014-093827. Epub 2014 Nov 13.
Reference Type
BACKGROUND
Masci L, Spang C, van Schie HT, Alfredson H. Achilles tendinopathy-do plantaris tendon removal and Achilles tendon scraping improve tendon structure? A prospective study using ultrasound tissue characterisation. BMJ Open Sport Exerc Med. 2015 May 2;1(1):e000005. doi: 10.1136/bmjsem-2015-000005. eCollection 2015.
Reference Type
BACKGROUND
Robinson JM, Cook JL, Purdam C, Visentini PJ, Ross J, Maffulli N, Taunton JE, Khan KM; Victorian Institute Of Sport Tendon Study Group. The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. Br J Sports Med. 2001 Oct;35(5):335-41. doi: 10.1136/bjsm.35.5.335.
Reference Type
BACKGROUND
Lintz F, Higgs A, Millett M, Barton T, Raghuvanshi M, Adams MA, Winson IG. The role of Plantaris Longus in Achilles tendinopathy: a biomechanical study. Foot Ankle Surg. 2011 Dec;17(4):252-5. doi: 10.1016/j.fas.2010.08.004. Epub 2010 Sep 15.
Reference Type
BACKGROUND
Khan KM, Forster BB, Robinson J, Cheong Y, Louis L, Maclean L, Taunton JE. Are ultrasound and magnetic resonance imaging of value in assessment of Achilles tendon disorders? A two year prospective study. Br J Sports Med. 2003 Apr;37(2):149-53. doi: 10.1136/bjsm.37.2.149.
Reference Type
BACKGROUND
Astrom M, Gentz CF, Nilsson P, Rausing A, Sjoberg S, Westlin N. Imaging in chronic achilles tendinopathy: a comparison of ultrasonography, magnetic resonance imaging and surgical findings in 27 histologically verified cases. Skeletal Radiol. 1996 Oct;25(7):615-20. doi: 10.1007/s002560050146.
Reference Type
BACKGROUND
McAuliffe S, McCreesh K, Culloty F, Purtill H, O'Sullivan K. Can ultrasound imaging predict the development of Achilles and patellar tendinopathy? A systematic review and meta-analysis. Br J Sports Med. 2016 Dec;50(24):1516-1523. doi: 10.1136/bjsports-2016-096288. Epub 2016 Sep 15.
Reference Type
BACKGROUND
de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010 Jan 13;303(2):144-9. doi: 10.1001/jama.2009.1986.
Reference Type
BACKGROUND
Alfredson H, Ohberg L. Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomised controlled trial. Knee Surg Sports Traumatol Arthrosc. 2005 May;13(4):338-44. doi: 10.1007/s00167-004-0585-6. Epub 2005 Feb 2.
Reference Type
BACKGROUND
Chan O, O'Dowd D, Padhiar N, Morrissey D, King J, Jalan R, Maffulli N, Crisp T. High volume image guided injections in chronic Achilles tendinopathy. Disabil Rehabil. 2008;30(20-22):1697-708. doi: 10.1080/09638280701788225.
Reference Type
BACKGROUND
Wheeler PC, Mahadevan D, Bhatt R, Bhatia M. A Comparison of Two Different High-Volume Image-Guided Injection Procedures for Patients With Chronic Noninsertional Achilles Tendinopathy: A Pragmatic Retrospective Cohort Study. J Foot Ankle Surg. 2016 Sep-Oct;55(5):976-9. doi: 10.1053/j.jfas.2016.04.017. Epub 2016 Jun 7.
Reference Type
BACKGROUND
Alfredson H, Pietila T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998 May-Jun;26(3):360-6. doi: 10.1177/03635465980260030301.
Reference Type
BACKGROUND
Roche AJ, Calder JD. Achilles tendinopathy: A review of the current concepts of treatment. Bone Joint J. 2013 Oct;95-B(10):1299-307. doi: 10.1302/0301-620X.95B10.31881.
Reference Type
BACKGROUND
Saxena A, Ramdath S Jr, O'Halloran P, Gerdesmeyer L, Gollwitzer H. Extra-corporeal pulsed-activated therapy ("EPAT" sound wave) for Achilles tendinopathy: a prospective study. J Foot Ankle Surg. 2011 May-Jun;50(3):315-9. doi: 10.1053/j.jfas.2011.01.003. Epub 2011 Mar 15.
Reference Type
BACKGROUND
Lynen N, De Vroey T, Spiegel I, Van Ongeval F, Hendrickx NJ, Stassijns G. Comparison of Peritendinous Hyaluronan Injections Versus Extracorporeal Shock Wave Therapy in the Treatment of Painful Achilles' Tendinopathy: A Randomized Clinical Efficacy and Safety Study. Arch Phys Med Rehabil. 2017 Jan;98(1):64-71. doi: 10.1016/j.apmr.2016.08.470. Epub 2016 Sep 14.
Reference Type
BACKGROUND
Daseler EH, Anson BJ. The Plantaris muscle an anatomical study of 750 specimens. J Bone Joint Surg [Am] 1943;25-A:822-827.
Reference Type
RESULT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FortiusClinic
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Evaluation of the Efficacy of Prolotherapy Treatment in Patients With Plantar Fasciitis: a Randomized Double-blind Study
NCT03731897
COMPLETED
NA
The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy
NCT00377910
COMPLETED
PHASE4
Efficacy of Platelet Rich Plasma in Plantar Fasciitis
NCT03857334
COMPLETED
NA
Comparison of the Effectiveness of USG and Palpation Guidance Steroid Injection in Patients With Plantar Fasciitis
NCT04709484
COMPLETED
NA
Effects of Autologous Blood Injection Versus Platelet Rich Plasma on Chronic Plantar Fasciitis
NCT05240872
COMPLETED
PHASE3
Amnios™ RT Outcomes Study
NCT04088383
COMPLETED
NA
Treatment of Early Phase Achilles Tendinopathy - the Effect of NSAIDs
NCT03401177
COMPLETED
NA
Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders
NCT06681051
RECRUITING
Plantar Fasciitis, Operation or Conservative Treatment
NCT02448316
COMPLETED
PHASE4
Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon
NCT01711307
TERMINATED
NA
Bunionectomy Study for Postoperative Analgesia (EPOCH 1)
NCT03295721
COMPLETED
PHASE3
A Pilot Study on the Onset of Action of KTP, 20% in the Treatment of Acute Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee
NCT00903994
COMPLETED
PHASE2
The Effect of Platelet Rich Plasma for the Treatment of Osteochondral Lesions of the Talus
NCT05795660
NOT_YET_RECRUITING
PHASE1
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
NCT00375934
COMPLETED
PHASE3
Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy
NCT03997812
COMPLETED
PHASE2
A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery
NCT02401750
COMPLETED
PHASE3
Study Assessing Pain Relief After Replacement of the Knee
NCT05260008
TERMINATED
PHASE2
Efficacy and Safety Study of Transdermal Therapeutic System (TTS) Fentanyl in Participants With Osteoarthritis Knee Pain
NCT01742897
COMPLETED
PHASE4
Study of Peri-Articular Anaesthetic for Replacement of the Knee
NCT03326180
COMPLETED
PHASE3
Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis
NCT04182672
COMPLETED
PHASE2
Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy
NCT04430088
UNKNOWN
PHASE3
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
NCT00366444
COMPLETED
PHASE3
Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain
NCT02915978
COMPLETED
PHASE2
Study of Postoperative Analgesia in Bunionectomy
NCT00890682
COMPLETED
PHASE3
Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain
NCT01272934
COMPLETED
PHASE3